Preventive treatments for breast cancer :: recent developments

José Enrique Alés-Martínez; Amparo Ruiz; José Ignacio Chacón; A. Lluch Hernández; Manuel Ramos Vázquez; Octavi Córdoba; Elena Aguirre; Agustí Barnadas i Molins; Carlos Jara Sánchez; Santiago González Santiago; A. Plazaola; Jesús Florián; Raquel Andrés Conejero; Pedro Sánchez Rovira; Adolfo Frau

doi:10.1007/s12094-014-1250-2

Preventive treatments for breast cancer : recent developments

José Enrique Alés-Martínez, Amparo Ruiz, José Ignacio Chacón, A. Lluch Hernández, Manuel Ramos Vázquez, Octavi Córdoba, Elena Aguirre, Agustí Barnadas i Molins, Carlos Jara Sánchez, Santiago González Santiago, A. Plazaola, Jesús Florián, Raquel Andrés Conejero, Pedro Sánchez Rovira, Adolfo Frau

Department of Medicine

Research output: Contribution to journal › Review article › Research › peer-review

9 Citations (Scopus)

Abstract

Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. Recent developments in the armamentarium of effective drugs for breast cancer prevention (namely exemestane and anastrozole), the new recommendation from the National Institute for Health and Care Excellence to use preventative drugs in women at high risk as well as updated Guidelines from the US Preventive Services Task Force and the American Society of Clinical Oncology should give renewed momentum to the pharmacological prevention of breast cancer. In this article we review recent major developments in the field and examine their ongoing repercussion for breast cancer prevention. As a practical example, the potential impact of preventive measures in Spain is evaluated and a course of practical actions is delineated.

Original language	English
Pages (from-to)	0257-263
Number of pages	7
Journal	Clinical & translational oncology
Volume	17
Issue number	4
DOIs	https://doi.org/10.1007/s12094-014-1250-2
Publication status	Published - 2015

Keywords

Aromatase inhibitors
BRCA
Breast cancer
Breast cancer prevention
GEICAM
Pharmacological prevention

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12094-014-1250-2

https://ddd.uab.cat/record/300278

Cite this

Alés-Martínez, J. E., Ruiz, A., Chacón, J. I., Lluch Hernández, A., Ramos Vázquez, M., Córdoba, O., Aguirre, E., Barnadas i Molins, A., Jara Sánchez, C., González Santiago, S., Plazaola, A., Florián, J., Andrés Conejero, R., Sánchez Rovira, P., & Frau, A. (2015). Preventive treatments for breast cancer : recent developments. Clinical & translational oncology, 17(4), 0257-263. https://doi.org/10.1007/s12094-014-1250-2

@article{6549925360cd44c29a63f1323467e293,

title = "Preventive treatments for breast cancer :: recent developments",

abstract = "Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. Recent developments in the armamentarium of effective drugs for breast cancer prevention (namely exemestane and anastrozole), the new recommendation from the National Institute for Health and Care Excellence to use preventative drugs in women at high risk as well as updated Guidelines from the US Preventive Services Task Force and the American Society of Clinical Oncology should give renewed momentum to the pharmacological prevention of breast cancer. In this article we review recent major developments in the field and examine their ongoing repercussion for breast cancer prevention. As a practical example, the potential impact of preventive measures in Spain is evaluated and a course of practical actions is delineated.",

keywords = "Aromatase inhibitors, BRCA, Breast cancer, Breast cancer prevention, GEICAM, Pharmacological prevention",

author = "Al{\'e}s-Mart{\'i}nez, {Jos{\'e} Enrique} and Amparo Ruiz and Chac{\'o}n, {Jos{\'e} Ignacio} and {Lluch Hern{\'a}ndez}, A. and {Ramos V{\'a}zquez}, Manuel and Octavi C{\'o}rdoba and Elena Aguirre and {Barnadas i Molins}, Agust{\'i} and {Jara S{\'a}nchez}, Carlos and {Gonz{\'a}lez Santiago}, Santiago and A. Plazaola and Jes{\'u}s Flori{\'a}n and {Andr{\'e}s Conejero}, Raquel and {S{\'a}nchez Rovira}, Pedro and Adolfo Frau",

year = "2015",

doi = "10.1007/s12094-014-1250-2",

language = "English",

volume = "17",

pages = "0257--263",

number = "4",

}

Alés-Martínez, JE, Ruiz, A, Chacón, JI, Lluch Hernández, A, Ramos Vázquez, M, Córdoba, O, Aguirre, E, Barnadas i Molins, A, Jara Sánchez, C, González Santiago, S, Plazaola, A, Florián, J, Andrés Conejero, R, Sánchez Rovira, P & Frau, A 2015, 'Preventive treatments for breast cancer : recent developments', Clinical & translational oncology, vol. 17, no. 4, pp. 0257-263. https://doi.org/10.1007/s12094-014-1250-2

TY - JOUR

T1 - Preventive treatments for breast cancer :

T2 - recent developments

AU - Alés-Martínez, José Enrique

AU - Ruiz, Amparo

AU - Chacón, José Ignacio

AU - Lluch Hernández, A.

AU - Ramos Vázquez, Manuel

AU - Córdoba, Octavi

AU - Aguirre, Elena

AU - Barnadas i Molins, Agustí

AU - Jara Sánchez, Carlos

AU - González Santiago, Santiago

AU - Plazaola, A.

AU - Florián, Jesús

AU - Andrés Conejero, Raquel

AU - Sánchez Rovira, Pedro

AU - Frau, Adolfo

PY - 2015

Y1 - 2015

N2 - Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. Recent developments in the armamentarium of effective drugs for breast cancer prevention (namely exemestane and anastrozole), the new recommendation from the National Institute for Health and Care Excellence to use preventative drugs in women at high risk as well as updated Guidelines from the US Preventive Services Task Force and the American Society of Clinical Oncology should give renewed momentum to the pharmacological prevention of breast cancer. In this article we review recent major developments in the field and examine their ongoing repercussion for breast cancer prevention. As a practical example, the potential impact of preventive measures in Spain is evaluated and a course of practical actions is delineated.

AB - Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. Recent developments in the armamentarium of effective drugs for breast cancer prevention (namely exemestane and anastrozole), the new recommendation from the National Institute for Health and Care Excellence to use preventative drugs in women at high risk as well as updated Guidelines from the US Preventive Services Task Force and the American Society of Clinical Oncology should give renewed momentum to the pharmacological prevention of breast cancer. In this article we review recent major developments in the field and examine their ongoing repercussion for breast cancer prevention. As a practical example, the potential impact of preventive measures in Spain is evaluated and a course of practical actions is delineated.

KW - Aromatase inhibitors

KW - BRCA

KW - Breast cancer

KW - Breast cancer prevention

KW - GEICAM

KW - Pharmacological prevention

UR - http://dialnet.unirioja.es/servlet/articulo?codigo=5024291

U2 - 10.1007/s12094-014-1250-2

DO - 10.1007/s12094-014-1250-2

M3 - Review article

C2 - 25445174

SN - 1699-3055

VL - 17

SP - 257

EP - 263

JO - Clinical & translational oncology

JF - Clinical & translational oncology

IS - 4

ER -